US Patent Number
The present invention relates isolation of anti-idiotypic antibody 1A7 raised against anti-GD2 mAb 14G2a and its use for the treatment of melanoma and small cell carcinoma. The antibody may be used as a substitute for isolated purified GD2 antigen in any appropriate application.
University of Kentucky Research Foundation, Lexington, Ky.
Chatterjee, Malaya and Foon, Kenneth A., "Anti-Idiotype Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma" (1997). Microbiology, Immunology & Molecular Genetics Faculty Patents. 2.